Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma

Published:2020-10-15 Issue:2 Volume:62 Page:323-329
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Liu Weiping¹^ORCID,Wu Meng¹,Xie Yan¹,Zhang Chen¹,Ping Lingyan¹,Feng Feier¹,Leng Xin¹,Mi Lan¹,Wang Xiaopei¹,Zhu Jun¹^ORCID,Song Yuqin¹^ORCID

Affiliation:

1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China

Funder

Capital’s Funds for Health Improvement and Research

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1834092

Reference28 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

2. Mortality of lymphoma and myeloma in China, 2004–2017: an observational study

3. Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016

4. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

5. Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey;Indian Journal of Hematology and Blood Transfusion;2024-07-26

2. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients;Transfusion Medicine and Hemotherapy;2022-09-05